Alector (ALEC) Amortizatization of Intangibles (2018 - 2026)
Alector (ALEC) reported Amortizatization of Intangibles of $667000.0 for Q1 2026, down 22.8% year-over-year from $864000.0 in Q1 2025, and down 46.47% quarter-over-quarter from $1.2 million in Q4 2025.
Alector (ALEC) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Amortizatization of Intangibles data on file, last reported at $667000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $667000.0, down 22.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (down 40.15% YoY), and the FY2025 annual result was $6.6 million, down 54.25% from the prior year.
- Amortizatization of Intangibles fell to $667000.0 in Q1 2026 per ALEC's latest filing, from $1.2 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $11.8 million in Q4 2024 and troughed at -$2.9 million in Q2 2024.
- A 5-year average of $1.6 million and a median of $821000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 1334.96% in 2024 and fell as far as 472.1% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $719000.0 in 2022, then rose by 14.19% to $821000.0 in 2023, then jumped by 1334.96% to $11.8 million in 2024, then tumbled by 89.42% to $1.2 million in 2025, then plunged by 46.47% to $667000.0 in 2026.
- Business Quant data shows ALEC's Amortizatization of Intangibles at $667000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 667,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 667,000.00 |
| Mar 31, 2026 | 667,000.00 |
| Dec 31, 2025 | 1.25 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 864,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Dec 31, 2024 | 11.78 Mn |
| Dec 31, 2024 | 11.78 Mn |
| Sep 30, 2024 | 873,000.00 |
| Sep 30, 2024 | 873,000.00 |
| Jun 30, 2024 | -2.85 Mn |
| Jun 30, 2024 | -2.85 Mn |
| Mar 31, 2024 | 4.58 Mn |
| Mar 31, 2024 | 4.58 Mn |
| Dec 31, 2023 | 821,000.00 |
| Dec 31, 2023 | 821,000.00 |